 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
August 1, 2012 2:17 AM
|
Researchers at UC Davis Health System in Sacramento have received approval for a $20 million grant proposal to refine a stem cell therapy for osteoporosis patients and test its effectiveness in clinical trials over the next four years.
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 2:34 PM
|
Internal Medicine Medical Article: A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer (◈ A phase 1 study of a chimeric monoclonal...
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 11:48 AM
|
Oncobiologics, Inc. announced today a collaboration agreement with XOMA Corporation to develop novel biotherapeutics based on engineering single-chain variable.
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 11:45 AM
|
CAMBRIDGE, Mass. July 31, 2012 - Mersana Therapeutics, Inc., a biopharmaceutical company developing its Fleximer® antibody-drug conjugate platform and (Mersana Therapeutics, Inc.
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 10:48 AM
|
CytomX, an antibody builder, added $11M to its series B.
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 10:39 AM
|
A high-throughput, automated platform of manufacturing cell line development for producing protein therapeutics is described.
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 4:17 AM
|
San Francisco ChronicleMelanoma treatment shows promise at UCSFSan Francisco ChronicleThe gene circulates around the tumor cells without soaking into them.
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 4:12 AM
|
|
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:29 PM
|
BBC NewsUniQure's Glybera Wins EU Backing as First Gene TherapyBusinessweekEurope is on the cusp of approving the first gene therapy to be sold on the market in a western nation, a product from UniQure BV designed to treat a rare disease that...
|
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:27 PM
|
Research from University of Oxford Has Provided New Information about ...Equities.comAccording to news reporting from Oxford, United Kingdom, by NewsRx journalists, researchers stated "Ipilimumab (Yervoy; Medarex and Bristol-Myers Squibb) is a...
|
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:23 PM
|
iBio, Inc.and GE Healthcare form new global allianceMarketWatch (press release)We look forward to working together on the development of a flexible and cost-effective plant-based manufacturing platform that has the potential to assist in the global...
|
|
Scooped by
Gilbert C FAURE
July 29, 2012 2:52 PM
|
Researchers Study Vaccine Created from Patient Blood Cells as Potential ...MarketWatch (press release)Researchers at Northwestern Brain Tumor Institute (NBTI) are seeking to understand if a vaccine made from a patient's own blood cells may slow the...
|
|
Scooped by
Gilbert C FAURE
July 29, 2012 3:19 AM
|
Specificity: CD253 Product Page: TNFSF10 antibody (OASA07564) Antibody Pair Available: OASA07564 Capture OASA07567 Detection Experiment Type: Mice and treatments, Antibodies, flow cytometry, and cell sorting ...
|
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 2:43 PM
|
Hematology Oncology | Newly approved cancer drugs increase morbidity and treatment-related mortality, according to results of a meta-analysis.
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 2:33 PM
|
Immune Responses can Be Generated Locally Within Human Melanoma Skin ...Newswise (press release)For the majority of immune responses mounted by our bodies, for example in response to invading microbes, the predominant sites of lymphocyte activation...
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 11:46 AM
|
Pfizer, one of the three companies behind the drug, said it did not improve either cognition or daily functioning compared to a placebo. (Alzheimer’s Drug (BAPINEUZUMAB - anti beta-amyloid monoclonal antibody) Fails (!
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 10:48 AM
|
Special Issue on First Congress on Controversies in Rheumatism and Autoimmunity: Rituximab — Shadow, illusion or light?
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 10:47 AM
|
The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine ...
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 4:27 AM
|
Paper highlights clinical and immunological activity of immatics' IMA901 in ...News-Medical.netimmatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today...
|
|
Scooped by
Gilbert C FAURE
July 31, 2012 4:16 AM
|
World's first dengue vaccine beats three virus strainsFox NewsSanofi's vaccine generated an antibody response for all four dengue virus types, but evidence of protection was only demonstrated against three of the four strains circulating in Thailand.
|
|
Scooped by
Gilbert C FAURE
July 30, 2012 2:34 PM
|
The Anti-IL17A Monoclonal Antibody Secukinumab in ...
|
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:28 PM
|
Published Findings In Human Gene Therapy Methods Journal Demonstrate ...MarketWatch (press release)"The clinical success of DNA-based therapies can be enhanced by employing optimized gene delivery methods," stated Dr.
|
|
Scooped by
Gilbert C FAURE
July 30, 2012 1:24 PM
|
New Published Paper Shows Efficacy of Lpath's Anti-LPA Antibody, Lpathomab ...MarketWatch (press release)Lpath utilized ImmuneY2 to discover an antibody against another bioactive lipid, sphingosine-1-phosphate (S1P).
|
|
Scooped by
Gilbert C FAURE
July 29, 2012 4:01 PM
|
89.3 KPCCCIRM awards $151 million in stem cell grants to 8 projects statewide89.3 KPCCThis week, California's public stem-cell agency awarded more than $150 million to advance research into eight diseases now under study by researchers at several...
|
|
Scooped by
Gilbert C FAURE
July 29, 2012 3:35 AM
|
Stem cell injections in dogs will become routine in the next two years and will probably cost less than $1000.
|
Scoop.it!
